Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10424 | 998 | 41.6 | 80% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | YC 1 | Author keyword | 69 | 61% | 7% | 74 |
2 | BAY 41 2272 | Author keyword | 58 | 80% | 4% | 36 |
3 | SOLUBLE GUANYLYL CYCLASE | Author keyword | 43 | 36% | 10% | 96 |
4 | BAY 58 2667 | Author keyword | 41 | 87% | 2% | 20 |
5 | SOLUBLE GUANYLATE CYCLASE | Author keyword | 26 | 27% | 8% | 82 |
6 | NO SENSITIVE GUANYLYL CYCLASE | Author keyword | 18 | 83% | 1% | 10 |
7 | HUMAN SOLUBLE GUANYLATE CYCLASE | Author keyword | 8 | 100% | 1% | 5 |
8 | MED FAK MA N1 | Address | 8 | 100% | 1% | 5 |
9 | GUANYLYL CYCLASE | Author keyword | 6 | 11% | 5% | 51 |
10 | BAY 41 8543 | Author keyword | 5 | 54% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | YC 1 | 69 | 61% | 7% | 74 | Search YC+1 | Search YC+1 |
2 | BAY 41 2272 | 58 | 80% | 4% | 36 | Search BAY+41+2272 | Search BAY+41+2272 |
3 | SOLUBLE GUANYLYL CYCLASE | 43 | 36% | 10% | 96 | Search SOLUBLE+GUANYLYL+CYCLASE | Search SOLUBLE+GUANYLYL+CYCLASE |
4 | BAY 58 2667 | 41 | 87% | 2% | 20 | Search BAY+58+2667 | Search BAY+58+2667 |
5 | SOLUBLE GUANYLATE CYCLASE | 26 | 27% | 8% | 82 | Search SOLUBLE+GUANYLATE+CYCLASE | Search SOLUBLE+GUANYLATE+CYCLASE |
6 | NO SENSITIVE GUANYLYL CYCLASE | 18 | 83% | 1% | 10 | Search NO+SENSITIVE+GUANYLYL+CYCLASE | Search NO+SENSITIVE+GUANYLYL+CYCLASE |
7 | HUMAN SOLUBLE GUANYLATE CYCLASE | 8 | 100% | 1% | 5 | Search HUMAN+SOLUBLE+GUANYLATE+CYCLASE | Search HUMAN+SOLUBLE+GUANYLATE+CYCLASE |
8 | GUANYLYL CYCLASE | 6 | 11% | 5% | 51 | Search GUANYLYL+CYCLASE | Search GUANYLYL+CYCLASE |
9 | BAY 41 8543 | 5 | 54% | 1% | 7 | Search BAY+41+8543 | Search BAY+41+8543 |
10 | CINACIGUAT | 5 | 54% | 1% | 7 | Search CINACIGUAT | Search CINACIGUAT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BOVINE LUNG | 67 | 45% | 11% | 113 |
2 | YC 1 | 66 | 63% | 7% | 66 |
3 | NITROSYL HEME | 35 | 86% | 2% | 18 |
4 | NITRIC OXIDE RECEPTOR | 33 | 83% | 2% | 19 |
5 | ACTIVITY REQUIRES | 29 | 58% | 3% | 33 |
6 | YC 1 BINDING SITE | 26 | 100% | 1% | 11 |
7 | YC 1 INDUCED ACTIVATION | 23 | 100% | 1% | 10 |
8 | ENZYME SUBUNITS | 23 | 55% | 3% | 29 |
9 | BAY 58 2667 | 21 | 90% | 1% | 9 |
10 | CEREBELLAR CELLS | 19 | 74% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Structure and Regulation of Soluble Guanylate Cyclase | 2012 | 85 | 164 | 74% |
Regulation of nitric oxide-sensitive guanylyl cyclase | 2003 | 270 | 134 | 69% |
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | 2006 | 238 | 144 | 57% |
Guanylate cyclase and the (NO)-N-./cGMP signaling pathway | 1999 | 550 | 97 | 48% |
Nitric oxide signaling: no longer simply on or off | 2006 | 126 | 71 | 59% |
Soluble guanylate cyclase | 2006 | 71 | 25 | 88% |
Soluble guanylyl cyclase: more secrets revealed | 2005 | 69 | 74 | 84% |
Heme-Dependent and Independent Soluble Guanylate Cyclase Activators and Vasodilation | 2010 | 12 | 56 | 79% |
Soluble guanylate cyclase: the forgotten sibling | 1997 | 211 | 70 | 57% |
Binding of YC-1/BAY 41-2272 to soluble guanylate cyclase: A new perspective to the mechanism of activation | 2010 | 9 | 40 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED FAK MA N1 | 8 | 100% | 0.5% | 5 |
2 | BIOTECNOL BIOMED V VILLAR PALASI | 4 | 67% | 0.4% | 4 |
3 | BIOCHEM RT500 | 4 | 75% | 0.3% | 3 |
4 | GEORGE P LIVANOS MARIANTHI SIMOU S | 3 | 50% | 0.4% | 4 |
5 | BIOTECHNOL BIOMED V VILLAR PALASI | 2 | 67% | 0.2% | 2 |
6 | PULM CRIT CARE 1 | 2 | 67% | 0.2% | 2 |
7 | ANESTHESIA CRIT CARE ANESTHESIA CRIT | 2 | 43% | 0.3% | 3 |
8 | PHARMD CARDIOVASC | 1 | 100% | 0.2% | 2 |
9 | JL CHAMBERS BIOMED BIOTECHNOL | 1 | 24% | 0.5% | 5 |
10 | PHARMACOL TOXICOL CLIN PHARM | 1 | 19% | 0.6% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000183122 | HEME SENSOR//FIXL//COOA |
2 | 0.0000179572 | TYPE II CGMP DEPENDENT PROTEIN KINASE//CGMP DEPENDENT PROTEIN KINASE//CANC MOL BIOL SECT |
3 | 0.0000176621 | CYTOCHROME P460//N N BIS CARBOXYMETHYL N N DINITROSO 1 4 PHENYLENEDIAMINE//NITROSYLHEME |
4 | 0.0000132996 | DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175 |
5 | 0.0000094583 | PDE 5 INHIBITION//PDE5//PHOSPHODIESTERASE 5 |
6 | 0.0000090741 | INSECT NERVOUS SYSTEM//MOL NEUROBIOL CELLULAR PHYSIOL//PLEUROBRANCHAEA |
7 | 0.0000087284 | NITROXYL//ANGELIS SALT//PILOTYS ACID |
8 | 0.0000065353 | C TYPE NATRIURETIC PEPTIDE//NATRIURETIC PEPTIDE RECEPTOR//ATRIAL NATRIURETIC PEPTIDE |
9 | 0.0000064602 | ALPHA BETA ADRENOCEPTOR BLOCKADE//KMUP 1//EUGENOSEDIN A |
10 | 0.0000059209 | S NITROSOTHIOLS//S NITROSYLATION//S NITROSOGLUTATHIONE |